Connect Biopharma Holdings (CNTB) Other Non-Current Liabilities (2024 - 2026)

Connect Biopharma Holdings (CNTB) has reported Other Non-Current Liabilities for 3 consecutive years, with $111000.0 the latest figure, recorded in Q1 2026.

• Quarterly Other Non-Current Liabilities fell 82.3% year-over-year to $111000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $111000.0 (down 82.3% YoY) and the FY2025 annual result came in at $114000.0, down 81.96% from the prior year.
• Other Non-Current Liabilities fell to $111000.0 in Q1 2026 per CNTB's latest filing, from $114000.0 in the prior quarter.
• Over the last five years, Other Non-Current Liabilities for CNTB reached as high as $632000.0 in Q4 2024 and fell as low as $111000.0 in Q1 2026.
• A 3-year average of $287333.3 and a median of $120000.0 in 2025 frame the typical range for Other Non-Current Liabilities.
• Annual changes were most pronounced in 2025 — Other Non-Current Liabilities tumbled 81.96% — and 2026, when it sank 82.3%.
• Year by year, Other Non-Current Liabilities stood at $632000.0 in 2024, then slumped by 81.96% to $114000.0 in 2025, then slipped by 2.63% to $111000.0 in 2026.
• According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $111000.0, $114000.0, and $118000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.